Fredun Pharmaceuticals (BOM:539730) Debt-to-Equity : 0.87 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals Debt-to-Equity?

Fredun Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹927 Mil. Fredun Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹128 Mil. Fredun Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹1,215 Mil. Fredun Pharmaceuticals's debt to equity for the quarter that ended in Mar. 2024 was 0.87.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fredun Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

BOM:539730' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.57 Med: 0.91 Max: 3.92
Current: 0.87

During the past 13 years, the highest Debt-to-Equity Ratio of Fredun Pharmaceuticals was 3.92. The lowest was 0.57. And the median was 0.91.

BOM:539730's Debt-to-Equity is ranked worse than
81.87% of 844 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs BOM:539730: 0.87

Fredun Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Fredun Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fredun Pharmaceuticals Debt-to-Equity Chart

Fredun Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.96

0.92

0.89

0.90

0.87

Fredun Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.90	N/A	0.58	N/A	0.87

Competitive Comparison of Fredun Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Fredun Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fredun Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fredun Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fredun Pharmaceuticals's Debt-to-Equity falls into.

Fredun Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fredun Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(927.119	+	127.981)	/	1214.712
	=	0.87

Fredun Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(927.119	+	127.981)	/	1214.712
	=	0.87

Fredun Pharmaceuticals (BOM:539730) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fredun Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fredun Pharmaceuticals (BOM:539730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013

Website

http://www.fredungroup.com

Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals (BOM:539730) Headlines

No Headlines